ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM15 | ADAM metallopeptidase domain 15 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM18 | ADAM metallopeptidase domain 18 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM19 | ADAM metallopeptidase domain 19 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM29 | ADAM metallopeptidase domain 29 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM30 | ADAM metallopeptidase domain 30 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADAM32 | ADAM metallopeptidase domain 32 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM33 | ADAM metallopeptidase domain 33 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM9 | ADAM metallopeptidase domain 9 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS10 | ADAM metallopeptidase with thrombospondin type 1 motif, 10 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS17 | ADAM metallopeptidase with thrombospondin type 1 motif, 17 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif, 18 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Not detected |
ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS7 | ADAM metallopeptidase with thrombospondin type 1 motif, 7 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
AEBP1 | AE binding protein 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
AGBL2 | ATP/GTP binding protein-like 2 | Enzymes
| | | | | Tissue enhanced |
AGBL3 | ATP/GTP binding protein-like 3 | Enzymes
| | | | | Mixed |
AGBL4 | ATP/GTP binding protein-like 4 | Enzymes
| | | | | Tissue enhanced |
AGBL5 | ATP/GTP binding protein-like 5 | Enzymes
| | | | | Tissue enriched |